23948sdkhjf

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines destined for the US market to be produced within the country.
The Swiss company will invest in ten manufacturing and research facilities in the USA, of which seven are brand new. The initiative is expected to create 1,000 new jobs at Novartis and generate an additional 4,000 jobs in the USA, according to a press release from the company.

Among other things, a new research hub is planned in San Diego, where t...
Vill du få åtkomst till allt?
Prova 30 dagar för 0 kr.
Inga bindningstider eller kortuppgifter krävs.
Prova nu
Köp en prenumeration
Utforska våra prenumerationslösningar och välj den som passar dina behov.
Välj din prenumeration
Utvalda artiklar

Nyhetsbrev

Sänd till en kollega

0.189